Ian Stansfield

Mechanismof Action and Antiviral Activity of Benzimidazole-Based AllostericInhibitors of the Hepatitis C Virus RNA-Dependent RNAPolymerase

Licia Tomei, Sergio Altamura, Linda Bartholomew et al. · Journal of Virology · 2003 · 190 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +17

The identification of clinical candidate SB-480848: a potent inhibitor of lipoprotein-associated phospholipase A2

Josie A. Blackie, Jackie C. Bloomer, Murray J. B. Brown et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 130 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +6

3-Acyl-4-hydroxyquinolin-2(1H)-ones. Systemically active anticonvulsants acting by antagonism at the glycine site of the N-methyl-D-aspartate receptor complex

Michael Rowley, Paul D. Leeson, Graeme I. Stevenson et al. · Journal of Medicinal Chemistry · 1993 · 88 citations

Medicine, Medicinal Chemistry, Pharmacology +16

Discovery of (7<i>R</i>)-14-Cyclohexyl-7-{[2-(dimethylamino)ethyl](methyl) amino}-7,8-dihydro-6<i>H</i>-indolo[1,2-<i>e</i>][1,5]benzoxazocine-11-carboxylic Acid (MK-3281), a Potent and Orally Bioavailable Finger-Loop Inhibitor of the Hepatitis C Virus NS5B Polymerase

Frank Narjes, Benedetta Crescenzi, Marco Ferrara et al. · Journal of Medicinal Chemistry · 2010 · 66 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Studies towards the identification of a new generation of atypical antipsychotic agents

Vincenzo Garzya, Ian T. Forbes, Andrew D. Gribble et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 52 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +10